Search results for "Highlights"


 
Results 91 - 100 of about 221 for "Highlights".
Sort by: Relevance | Newest | Oldest

AGA releases new guidance on coagulation disorders in patients with cirrhosis

A clinical practice guideline from the American Gastroenterological Association (AGA) suggested against extensive preprocedural testing in patients with stable cirrhosis who are undergoing routine GI procedures, among other recommendations.
https://gastroenterology.acponline.org/archives/2021/11/19/3.htm
19 Nov 2021

New guidance on diagnosis, management of acute hepatic porphyrias

These genetic errors of heme metabolism, although rare, appear to be more common than previously thought, and recent treatment advances have improved the outlook for patients with the diagnoses, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/01/27/1.htm
27 Jan 2023

HCV medications decreased liver disease among those using injection drugs

A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022

More concentrated care linked to adverse outcomes in patients with cirrhosis

A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
https://gastroenterology.acponline.org/archives/2020/01/24/2.htm
24 Jan 2020

In adults using oral anticoagulants, PPI use may be associated with lower risk for upper GI bleeding

An ACP Journal Club commentary on the meta-analysis stressed the importance of assessing patients' underlying risk for GI bleeding and using overall clinical risk to guide shared decision making in those at higher risk or with lower baseline bleeding tolerance.
https://gastroenterology.acponline.org/archives/2022/11/18/9.htm
18 Nov 2022

Induction, maintenance therapies for ulcerative colitis compared

Oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine, controlled ileal-release budesonide, and budesonide multimatrix, alone or in combination with rectal 5-ASA therapy, were assessed for comparative efficacy and tolerability.
https://gastroenterology.acponline.org/archives/2018/08/24/3.htm
24 Aug 2018

Safe to stop 5-ASA therapy for Crohn's disease when anti-TNF agent is started, study finds

A retrospective trial showed no increase in new corticosteroid therapy or disease-related hospitalization or surgery among patients who discontinued 5-aminosalycilate (5-ASA) therapy when initiating an anti-tumor necrosis factor (anti-TNF) agent.
https://gastroenterology.acponline.org/archives/2019/08/23/3.htm
23 Aug 2019

Combination therapy for IBD carries higher infection risk than monotherapy

Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a meta-analysis.
https://gastroenterology.acponline.org/archives/2019/03/22/2.htm
22 Mar 2019

Severe COVID-19 associated with more IBS, less constipation

A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.
https://gastroenterology.acponline.org/archives/2022/12/23/1.htm
23 Dec 2022

Person-to-person transmission now more common source of hepatitis A in U.S. than food

An analysis of hepatitis outbreaks in 2016 to 2020, comprising 37,553 cases, found that 56% of patients reported drug use, 14% reported homelessness, 12% reported recent incarceration, and 3% reported recent international travel.
https://gastroenterology.acponline.org/archives/2022/10/28/1.htm
28 Oct 2022

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next